To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1087814
Sale price1.055,10 €
|
Candesartan Cilexetil Related Compound A (10 mg) (Ethyl 1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylate) |
F03411 | 139481-58-6 | 1.055,10 € | |
|
USP-1087825
Sale price1.086,65 €
|
Candesartan Cilexetil Related Compound B (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate) |
R11881 | 869631-11-8 | 1.086,65 € | |
|
USP-1087847
Sale price1.028,23 €
|
Candesartan Cilexetil Related Compound D (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylates) |
F03431 | 1185256-03-4 | 1.028,23 € | |
|
USP-1087869
Sale price1.107,68 €
|
Candesartan Cilexetil Related Compound F (10 mg) (1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylates) |
F03441 | 914613-36-8 | 1.107,68 € | |
|
USP-1087870
Sale price1.055,10 €
|
Candesartan Cilexetil Related Compound G (10 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylic acid) |
R136H0 | 139481-59-7 | 1.055,10 € | |
|
USP-1090014
Sale price433,49 €
|
Exo-tetrahydrocannabinol (1 mL) ((6aR,10aR)-6,6-Dimethyl-9-methylene-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol) |
R090H0 | 27179-28-8 | 433,49 € | |
|
USP-1090717
Sale price1.008,37 €
|
Capecitabine Related Compound A (15 mg) (5'-deoxy-5-fluorocytidine) |
R01540 | 66335-38-4 | 1.008,37 € | |
|
USP-1090728
Sale price1.086,65 €
|
Capecitabine Related Compound B (20 mg) (5'-deoxy-5-fluorouridine) |
R103A0 | 3094-09-5 | 1.086,65 € | |
|
USP-1090739
Sale price1.079,64 €
|
Capecitabine Related Compound C (10 mg) (2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine |
R11620 | 921769-65-5 | 1.079,64 € | |
